Bank of Nova Scotia’s Bionano Genomics BNGO Stock Holding History

Bank of Nova Scotia’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$244K	–	1074
2021 Q1	$244K	Buy	+50	New	+$282K	﹤0.01%	1022

Other funds holding BNGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Bank of Nova Scotia's BNGO Position: Q2 2021 in Review

Bank of Nova Scotia sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 50 shares — an estimated $244K sold.

Bank of Nova Scotia first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $244K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

Bank of Nova Scotia reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
Bank of Nova Scotia sold 50 Bionano Genomics shares in Q2 2021, an estimated $244K.
Bank of Nova Scotia first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
Bank of Nova Scotia's Bionano Genomics position peaked at $244K in Q1 2021.
152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Bank of Nova Scotia's 13F filing for Q2 2021, filed 12 Aug 2021.